BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16611000)

  • 1. Vaccine delivery--current trends and future.
    Azad N; Rojanasakul Y
    Curr Drug Deliv; 2006 Apr; 3(2):137-46. PubMed ID: 16611000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antigen delivery technologies: a review.
    Jain D; Jain V; Singh R
    Drug Deliv Transl Res; 2011 Apr; 1(2):103-12. PubMed ID: 25788109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles as vaccine adjuvants and delivery systems.
    O'Hagan DT; Singh M
    Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery.
    Garg N; Aggarwal A
    Indian J Pediatr; 2018 Feb; 85(2):132-138. PubMed ID: 28620730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in vaccine delivery systems.
    O'Hagan DT
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of antigens and adjuvants in vaccine development.
    Zhao Z; Leong KW
    J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully mobilizing host defense: building better vaccines.
    Raychaudhuri S; Rock KL
    Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to vaccine delivery.
    O'Hagan DT; Rappuoli R
    Pharm Res; 2004 Sep; 21(9):1519-30. PubMed ID: 15497674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
    Jones SD
    IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
    Davis SS
    Vaccine; 2006 Apr; 24 Suppl 2():S2-7-10. PubMed ID: 16823907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle-free epidermal powder immunization.
    Chen D; Maa YF; Haynes JR
    Expert Rev Vaccines; 2002 Oct; 1(3):265-76. PubMed ID: 12901567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of vaccines and positioning of current trends.
    Payette PJ; Davis HL
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):241-7. PubMed ID: 12455398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards tailored vaccine delivery: needs, challenges and perspectives.
    Amorij JP; Kersten GF; Saluja V; Tonnis WF; Hinrichs WL; Slütter B; Bal SM; Bouwstra JA; Huckriede A; Jiskoot W
    J Control Release; 2012 Jul; 161(2):363-76. PubMed ID: 22245687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of DNA vaccines and their route of administration.
    Alpar HO; Bramwell VW
    Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):307-83. PubMed ID: 12661697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.